SCHEMBL1919161

SCHEMBL1919161

COC(N)CC(C)S(=O)(=O)O

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.33
CA14 Q9ULX7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14955405 0.77 TP53 (0.37) TP53
SCHEMBL6720279 0.72 SLC7A5 (0.40) TP53
SCHEMBL1920398 0.71
SCHEMBL11878195 0.71 TP53 (0.35) TP53
SCHEMBL751960 0.71 MAPK1 (0.32) TP53
SCHEMBL11872650 0.70 TSHR (0.33) TP53
Hydrochloric Acid SCHEMBL27819023 0.70 SLC7A5 (0.39) TP53
SCHEMBL6687959 0.70 TP53 (0.33) TP53
SCHEMBL16826690 0.70
SCHEMBL13497871 0.70 ANPEP (0.42) TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2326619-A2 METHIONINE ANALOGS AND METHODS OF USING SAME Bioxiness Pharmaceuticals, Inc. (US) 2011-06-01 EP disclosed
WO-2010014943-A2 METHIONINE ANALOGS AND METHODS OF USING SAME BIOXINESS PHARMACEUTICS, INC. (US) 2010-02-04 WO disclosed